The North America Uveitis Treatment Market would witness market growth of 4.98% CAGR during the forecast period (2019-2025). Iontophoresis is the use of electric current to help move molecules through the epithelium of the hydrophilic cornea, traditionally the greatest barrier to the penetration of medicines into the eye. It would potentially increase the steroid medication's bioavailability, allowing for significantly reduced dosing frequency and improved effectiveness compared to topical corticosteroids. This procedure has the advantage of not being connected to many of the needle-related complications associated with many local procedures.
Treatment of post-infectious uveitis is a medical problem for ophthalmologists. The eye is a privileged site, preserved by blood ocular barriers that restrict the penetration of systemic antimicrobials into the corresponding segment. Furthermore, intraocularly, topical and subconjunctival treatments are unable to generate adequate concentrations of the medicines. Post-infectious uveitis can result from bacteria, viruses, fungi, or protozoa. The treatment method varies widely depending on the etiology of infections.
Based on Drug Class, the market is segmented into Anti-inflammatory, Immunotherapy & Targeted Therapies, Antimicrobial Drugs and Other Drug Class. Based on Disease Type, the market is segmented into Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis and Panuveitis. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies and Online stores. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: Uveitis Treatment Market in North America is expected to register a CAGR of 4.98% during the forecast period (2019-2025)
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include AbbVie, Inc., Alimera Sciences, Inc., Enzo Biochem, Inc., Amgen, Inc., Bausch Health Companies, Inc., Clearside Biomedical, Inc., EyePoint Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., TopiVert Ltd., and Novartis AG.
Scope of the North America Uveitis Treatment Market Analysis
Market Segmentation:
By Drug Class
- Anti-inflammatory
- Immunotherapy & Targeted Therapies
- Antimicrobial Drugs
- Other Drug Class
By Disease Type
- Anterior Uveitis
- Posterior Uveitis
- Intermediate Uveitis
- Panuveitis
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online stores
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- AbbVie, Inc.
- Alimera Sciences, Inc.
- Enzo Biochem, Inc.
- Amgen, Inc.
- Bausch Health Companies, Inc.
- Clearside Biomedical, Inc.
- EyePoint Pharmaceuticals, Inc.
- Santen Pharmaceutical Co., Ltd.
- TopiVert Ltd.
- Novartis AG
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Uveitis Treatment Market, by Drug Class
1.4.2 North America Uveitis Treatment Market, by Disease Type
1.4.3 North America Uveitis Treatment Market, by Distribution Channel
1.4.4 North America Uveitis Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Uveitis Treatment Market by Drug Class
3.1 North America Anti-inflammatory Market by Country
3.2 North America Immunotherapy & Targeted Therapies Market by Country
3.3 North America Antimicrobial Drugs Market by Country
3.4 North America Other Drug Class Market by Country
Chapter 4. North America Uveitis Treatment Market by Disease Type
4.1 North America Anterior Uveitis Market by Country
4.2 North America Posterior Uveitis Market by Country
4.3 North America Intermediate Uveitis Market by Country
4.4 North America Other Disease Types Market by Country
Chapter 5. North America Uveitis Treatment Market by Distribution Channel
5.1 North America Hospital Pharmacies Market by Country
5.2 North America Retail Pharmacies Market by Country
5.3 North America Online stores Market by Country
Chapter 6. North America Uveitis Treatment Market by Country
6.1 USA Uveitis Treatment Market
6.1.1 USA Uveitis Treatment Market by Drug Class
6.1.2 USA Uveitis Treatment Market by Disease Type
6.1.3 USA Uveitis Treatment Market by Distribution Channel
6.2 Canada Uveitis Treatment Market
6.2.1 Canada Uveitis Treatment Market by Drug Class
6.2.2 Canada Uveitis Treatment Market by Disease Type
6.2.3 Canada Uveitis Treatment Market by Distribution Channel
6.3 Mexico Uveitis Treatment Market
6.3.1 Mexico Uveitis Treatment Market by Drug Class
6.3.2 Mexico Uveitis Treatment Market by Disease Type
6.3.3 Mexico Uveitis Treatment Market by Distribution Channel
6.4 Rest of North America Uveitis Treatment Market
6.4.1 Rest of North America Uveitis Treatment Market by Drug Class
6.4.2 Rest of North America Uveitis Treatment Market by Disease Type
6.4.3 Rest of North America Uveitis Treatment Market by Distribution Channel
Chapter 7. Company Profiles
7.1 AbbVie, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Approvals:
7.2 Alimera Sciences, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Product Launches and Product Expansions:
7.3 Enzo Biochem, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Amgen, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Research & Development Expense
7.4.4 Recent strategies and developments:
7.4.4.1 Product Launches and Product Expansions:
7.4.4.2 Partnerships, Collaborations, and Agreements:
7.5 Bausch Health Companies, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Clearside Biomedical, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Research & Development Expense
7.6.4 Recent strategies and developments:
7.6.4.1 Partnerships, Collaborations, and Agreements:
7.7 EyePoint Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Santen Pharmaceutical Co., Ltd.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Topivert Ltd.
7.9.1 Company Overview
7.1 Novartis AG
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Recent strategies and developments:
7.10.4.1 Acquisition and Mergers:
7.10.4.2 Approvals:
7.10.5 Research & Development Expense
TABLE 1 North America Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 2 North America Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 3 North America Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 4 North America Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 5 North America Anti-inflammatory Market by Country, 2015 - 2018, USD Million
TABLE 6 North America Anti-inflammatory Market by Country, 2019 - 2025, USD Million
TABLE 7 North America Immunotherapy & Targeted Therapies Market by Country, 2015 - 2018, USD Million
TABLE 8 North America Immunotherapy & Targeted Therapies Market by Country, 2019 - 2025, USD Million
TABLE 9 North America Antimicrobial Drugs Market by Country, 2015 - 2018, USD Million
TABLE 10 North America Antimicrobial Drugs Market by Country, 2019 - 2025, USD Million
TABLE 11 North America Other Drug Class Market by Country, 2015 - 2018, USD Million
TABLE 12 North America Other Drug Class Market by Country, 2019 - 2025, USD Million
TABLE 13 North America Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 14 North America Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 15 North America Anterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 16 North America Anterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 17 North America Posterior Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 18 North America Posterior Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 19 North America Intermediate Uveitis Market by Country, 2015 - 2018, USD Million
TABLE 20 North America Intermediate Uveitis Market by Country, 2019 - 2025, USD Million
TABLE 21 North America Other Disease Types Market by Country, 2015 - 2018, USD Million
TABLE 22 North America Other Disease Types Market by Country, 2019 - 2025, USD Million
TABLE 23 North America Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 24 North America Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 25 North America Hospital Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 26 North America Hospital Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 27 North America Retail Pharmacies Market by Country, 2015 - 2018, USD Million
TABLE 28 North America Retail Pharmacies Market by Country, 2019 - 2025, USD Million
TABLE 29 North America Online stores Market by Country, 2015 - 2018, USD Million
TABLE 30 North America Online stores Market by Country, 2019 - 2025, USD Million
TABLE 31 North America Uveitis Treatment Market by Country, 2015 - 2018, USD Million
TABLE 32 North America Uveitis Treatment Market by Country, 2019 - 2025, USD Million
TABLE 33 USA Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 34 USA Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 35 USA Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 36 USA Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 37 USA Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 38 USA Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 39 USA Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 40 USA Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 41 Canada Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 42 Canada Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 43 Canada Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 44 Canada Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 45 Canada Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 46 Canada Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 47 Canada Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 48 Canada Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 49 Mexico Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 50 Mexico Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 51 Mexico Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 52 Mexico Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 53 Mexico Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 54 Mexico Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 55 Mexico Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 56 Mexico Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 57 Rest of North America Uveitis Treatment Market, 2015 - 2018, USD Million
TABLE 58 Rest of North America Uveitis Treatment Market, 2019 - 2025, USD Million
TABLE 59 Rest of North America Uveitis Treatment Market by Drug Class, 2015 - 2018, USD Million
TABLE 60 Rest of North America Uveitis Treatment Market by Drug Class, 2019 - 2025, USD Million
TABLE 61 Rest of North America Uveitis Treatment Market by Disease Type, 2015 - 2018, USD Million
TABLE 62 Rest of North America Uveitis Treatment Market by Disease Type, 2019 - 2025, USD Million
TABLE 63 Rest of North America Uveitis Treatment Market by Distribution Channel, 2015 - 2018, USD Million
TABLE 64 Rest of North America Uveitis Treatment Market by Distribution Channel, 2019 - 2025, USD Million
TABLE 65 Key information – AbbVie, Inc.
TABLE 66 Key Information – Alimera Sciences, Inc.
TABLE 67 key information – Enzo Biochem, Inc.
TABLE 68 Key Information – Amgen, Inc.
TABLE 69 key information – Bausch Health Companies, Inc.
TABLE 70 Key Information – Clearside Biomedical, Inc.
TABLE 71 Key Information – EyePoint Pharmaceuticals, Inc.
TABLE 72 Key Information – Santen Pharmaceutical Co., Ltd.
TABLE 73 Key Information – Topivert Ltd.
Table 370 Key Information – Novartis AG
List of Figures
FIG 1 Methodology for the research